When it comes to gonorrhea, gender matters
For More Information or to Request a Photo from this News Release, Contact:
BOSTON (June 27, 2018, 1:00 p.m. ET)—The World Health Organization estimates that 78 million people worldwide are infected with gonorrhea each year. Men with infections tend to have obvious symptoms while women are often asymptomatic or experience mild symptoms. In both men and women, the infection usually clears with antibiotic treatment.
In the last decade, however, there has been an emergence of strains of antimicrobial-resistant Neisseria gonorrhoeae, the bacterial pathogen responsible for gonorrhea, and in 2013, the Centers for Disease Control and Prevention listed drug-resistant N. gonorrhoeae as an urgent public health threat.
In a new NIH-funded pilot study published today in mSphere, a team led by researchers from Tufts University School of Medicine conducted the first full comparison of gonococcal gene expression and regulation in both men and women infected with N. gonorrhoeae, identifying gender-specific signatures in infection and in antibiotic resistance genes.
“We built on our earlier work on gene expression during infection in females to include both genders in the present analysis, so we see for the first time the expression profiles during active disease in males and their asymptomatic partners,” said Caroline A. Genco, Ph.D., Arthur E. Spiller Professor and Chair of the Department of Immunology at Tufts University School of Medicine and senior and corresponding author of the study. “We found that when the bacteria are infecting the male, it’s a different gene expression profile compared to when they are infecting the female. When you consider how fundamentally different the two host environments are, this makes sense.”
Until now, infection has been primarily studied in tissue culture, male human models, and mice. While these studies have provided some key information on interactions between the bacteria and the host, “they have important limitations, namely the absence of the female response in humans,” Genco added. “Studying active, natural infection in both men and women is critical to develop strategies to treat and prevent infection.”
To understand the disease in both genders, the team looked at disease manifestation in a cohort of subjects attending a clinic that treats sexually transmitted infections in a country where there are high rates of gonorrhea and antibiotic resistance. Specimens were collected from males who went to the clinic for treatment for gonorrhea and from the female partners who came in for treatment following confirmation of their partner’s diagnosis.
The researchers used RNA-sequencing to identify what host and bacterial genes are expressed during mucosal infection.
The analysis revealed that 9 percent of gonococcal genes showed increased expression exclusively in men and included genes involved in host immune cell interactions. Four percent of genes showed increased expression exclusively in women and included phage-associated genes.
In whole genome DNA sequencing, men and women displayed similar antibiotic-resistant genotypes, but researchers observed an expression of these antibiotic-resistant genes four times higher in men.
The researchers note that limitations include the small sample size and the potential variance in stages of infection in the male subjects compared to the female. A larger-scale study employing additional genetic analysis is currently underway.
Genco is also a member of the Immunology; Molecular Microbiology; Cell, Molecular & Developmental Biology; and Pharmacology & Drug Development program faculty at the Sackler School of Graduate Biomedical Sciences at Tufts.
This study was supported by awards from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (U19AI084048 and R01AI048611). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Co-first authors of this study are Kathleen Nudel, Ph.D., a former postdoctoral scholar in Genco’s laboratory at Tufts University School of Medicine, and Ryan McClure, Ph.D., a former graduate student at Boston University School of Medicine, currently at Pacific Northwest National Laboratory.
Additional authors on this study are Matthew Moreau, Ph.D., Tufts University School of Medicine; Emma Briars, Ph.D. student, Boston University; A. Jeanine Abrams, Ph.D., Centers for Disease Control and Prevention; Brian Tjaden, Ph.D., Wellesley College; Xiao-Hong Su, M.D., Ph.D., Chinese Academy of Medical Sciences and Peking Union Medical College; David Trees, Ph.D., Centers for Disease Control and Prevention; Peter A. Rice, M.D., University of Massachusetts Medical School; Paola Massari, Ph.D., Tufts University School of Medicine.
Nudel, K., McClure, R., Moreau, M., Briars, E., Abrams, A. J., Tjaden, B., Su, X.H., Trees, D., Rice, P. A., Massari, P, & Genco, C. A. (2018). Transcriptome analysis of Neisseria gonorrhoeae during natural infection reveals differential expression of antibiotic resistance determinants between men and women. mSphere. doi: 10.1128/mSphere.00312-18
About Tufts University School of Medicine
Tufts University School of Medicine is an international leader in medical and population health education and advanced research. Tufts University School of Medicine emphasizes rigorous fundamentals in a dynamic learning environment to educate physicians, scientists, and public health professionals to become leaders in their fields. The School of Medicine is renowned for excellence in education in general medicine, the biomedical sciences, and public health, as well as for research at the cellular, molecular, and population health level. The School of Medicine is affiliated with six major teaching hospitals and more than 30 health care facilities. Tufts University School of Medicine undertakes research that is consistently rated among the highest in the nation for its effect on the advancement of medical and prevention science.